This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Sixth Streetlending Partners, as the Administrative Agent. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Dawn Christianson: Innovator in Alpha-1 Antitrypsin Deficiency Treatment
Introduction
Dawn Christianson is a notable inventor based in Pasadena, CA (US). She has made significant contributions to the field of medicine, particularly in the treatment of Alpha-1 Antitrypsin Deficiency (AATD). Her innovative work has the potential to improve the lives of many individuals affected by this condition.
Latest Patents
Dawn holds a patent for "Methods for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)." This patent represents her commitment to advancing medical treatments and addressing critical health issues.
Career Highlights
Dawn is currently employed at Sixth Street Lending Partners, where she serves as the Administrative Agent. Her role in this company allows her to leverage her expertise in a professional setting, contributing to the company's mission and goals.
Collaborations
Dawn collaborates with esteemed colleagues, including Bruce Given and James C. Hamilton. These partnerships enhance her work and foster innovation in her field.
Conclusion
Dawn Christianson is a pioneering inventor whose work in treating Alpha-1 Antitrypsin Deficiency showcases her dedication to medical innovation. Her contributions are invaluable to the advancement of healthcare solutions.